The effect of manganese on dopamine toxicity and dopamine transporter (DAT) in control and DAT transfected HEK cells

Jerome A Roth1, Zhezheng Li, Swetha Sridhar

  • 1Department of Pharmacology and Toxicology, University at Buffalo, Buffalo, NY 14214, United States. jaroth@buffalo.edu

Neurotoxicology
|January 15, 2013
PubMed

Insights

Manganese (Mn) exposure causes manganism, a Parkinsonism-like disorder. Mn disrupts dopamine (DA) transmission by reducing dopamine transporter (DAT) function and promoting DAT internalization, impacting neurological health.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Chronic manganese (Mn) exposure leads to manganism, a neurological disorder with Parkinsonism-like symptoms.
  • While dopaminergic neurons are intact, Mn disrupts dopamine (DA) transmission, decreasing amphetamine-induced DA release and affecting the dopamine transporter (DAT).

Purpose of the Study:

  • To investigate the effects of Mn and DA on cell viability in HEK cells with and without DAT.
  • To elucidate the mechanism by which Mn disrupts DA transmission and DAT function.

Main Methods:

  • Evaluating cell viability in control and DAT-transfected HEK cells exposed to Mn and/or DA.
  • Assessing DA uptake and amphetamine-induced DA efflux in DAT-containing cells.
  • Utilizing time-lapsed confocal microscopy to observe DAT trafficking.

Main Results:

  • Mn is toxic to both cell lines; DA is toxic only to DAT-containing cells, indicating saturable transport.
  • Simultaneous Mn and DA exposure showed Mn toxicity alone, suggesting Mn suppresses DA uptake.
  • Mn exposure decreased DA uptake and efflux, and promoted DAT internalization from the cell surface into intracellular compartments.

Conclusions:

  • Mn disrupts DA transmission by impairing DAT function, potentially through internalization.
  • Mn-induced DAT trafficking provides a mechanism for observed disruptions in striatal DA transmission.
  • Understanding Mn's effect on DAT is crucial for addressing manganism-related neurological deficits.